Endometrioid adenocarcinoma arising in endometriosis foci six years after estrogen replacement therapy: a case report

• Published in: European journal of gynaecological oncology Vol. 25; no. 2; p. 255
• Main Authors: Areia, A, Sousa, V, Frutuoso, C, Dias, I, Martins, M I, de Oliveira, C F
• Format: Journal Article
• Language: English
• Published: Italy 2004
• Subjects: Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Carcinoma, Endometrioid - complications; Carcinoma, Endometrioid - diagnosis; Carcinoma, Endometrioid - drug therapy; Carcinoma, Endometrioid - secondary; Cisplatin - administration & dosage; Diagnosis, Differential; Doxorubicin - administration & dosage; Endometriosis - pathology; Female; Humans; Middle Aged; Rectal Neoplasms - diagnosis; Rectal Neoplasms - drug therapy; Rectal Neoplasms - secondary; Urinary Bladder Neoplasms - diagnosis; Urinary Bladder Neoplasms - drug therapy; Urinary Bladder Neoplasms - secondary; Uterine Hemorrhage - etiology; Vaginal Neoplasms - complications; Vaginal Neoplasms - diagnosis; Vaginal Neoplasms - drug therapy; Vaginal Neoplasms - pathology

We present a case of a 53-year-old woman who developed an endometrioid adenocarcinoma six years after total abdominal hysterectomy (TAH) and bilateral salpingo-oophorectomy (BSO), who was on estrogenic-only hormone replacement therapy (HRT).